Glucagon-like peptide-1 receptor agonists linked to a reduced risk of developing asthma among patients with type 2 diabetes

Background: Studies have suggested that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may modulate asthma-related immune pathways, but evidence directly linking the use of GLP-1 RAs to asthma onset remains limited. Objectives: We aimed to evaluate whether the use of GLP-1 RAs in patients wit...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yung-Sheng Cheng, Chi-Hsiang Chung, Shih-Ming Kuo, Chih-Ping Lin, Tsu-Hsuan Weng, Sheng-Chiang Su, Chieh-Hua Lu, Feng-Chih Kuo, Wu-Chien Chien, Yao-Jen Liang, Peng-Fei Li
Format:	Artigo
Idioma:	Inglês
Publicat:	SAGE Publishing 2025-12-01
Col·lecció:	Therapeutic Advances in Endocrinology and Metabolism
Accés en línia:	https://doi.org/10.1177/20420188251400536
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!